BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 10193778)

  • 1. The effects of phosphodiesterase type 4 inhibitors on tumour necrosis factor-alpha and leukotriene B4 in a novel human whole blood assay.
    Brideau C; Van Staden C; Styhler A; Rodger IW; Chan CC
    Br J Pharmacol; 1999 Feb; 126(4):979-88. PubMed ID: 10193778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine A2 receptor-induced inhibition of leukotriene B4 synthesis in whole blood ex vivo.
    Krump E; Lemay G; Borgeat P
    Br J Pharmacol; 1996 Apr; 117(8):1639-44. PubMed ID: 8732271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preferential inhibition of human phosphodiesterase 4 by ibudilast.
    Huang Z; Liu S; Zhang L; Salem M; Greig GM; Chan CC; Natsumeda Y; Noguchi K
    Life Sci; 2006 May; 78(23):2663-8. PubMed ID: 16313925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro differentiation of human monocytes to macrophages: change of PDE profile and its relationship to suppression of tumour necrosis factor-alpha release by PDE inhibitors.
    Gantner F; Kupferschmidt R; Schudt C; Wendel A; Hatzelmann A
    Br J Pharmacol; 1997 May; 121(2):221-31. PubMed ID: 9154331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation.
    Meja KK; Barnes PJ; Giembycz MA
    Br J Pharmacol; 1997 Sep; 122(1):149-57. PubMed ID: 9298541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial lipopolysaccharides prime human neutrophils for enhanced production of leukotriene B4.
    Doerfler ME; Danner RL; Shelhamer JH; Parrillo JE
    J Clin Invest; 1989 Mar; 83(3):970-7. PubMed ID: 2537852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphodiesterase 4-dependent regulation of cyclic AMP levels and leukotriene B4 biosynthesis in human polymorphonuclear leukocytes.
    Denis D; Riendeau D
    Eur J Pharmacol; 1999 Feb; 367(2-3):343-50. PubMed ID: 10079010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of leukotriene B4 by activated human polymorphonuclear granulocytes.
    Brom J; Schönfeld W; König W
    Immunology; 1988 Jul; 64(3):509-18. PubMed ID: 2842254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of lipopolysaccharide-induced tumor necrosis factor-alpha generation from human peripheral blood monocytes by inhibitors of phosphodiesterase 4: interaction with stimulants of adenylyl cyclase.
    Seldon PM; Barnes PJ; Meja K; Giembycz MA
    Mol Pharmacol; 1995 Oct; 48(4):747-57. PubMed ID: 7476903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of inhibition of ovalbumin-induced bronchoconstriction in guinea pigs and in vitro inhibition of tumor necrosis factor-alpha formation with phosphodiesterase 4 (PDE4) selective inhibitors.
    Muise ES; Chute IC; Claveau D; Masson P; Boulet L; Tkalec L; Pon DJ; Girard Y; Frenette R; Mancini JA
    Biochem Pharmacol; 2002 Apr; 63(8):1527-35. PubMed ID: 11996895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of PDE4 inhibitors on lipopolysaccharide-induced priming of superoxide anion production from human mononuclear cells.
    Germain N; Corbel M; Belleguic C; Boichot E; Lagente V
    Mediators Inflamm; 2001 Jun; 10(3):117-23. PubMed ID: 11545248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-10 does not mediate the inhibitory effect of PDE-4 inhibitors and other cAMP-elevating drugs on lipopolysaccharide-induced tumors necrosis factor-alpha generation from human peripheral blood monocytes.
    Seldon PM; Barnes PJ; Giembycz MA
    Cell Biochem Biophys; 1998; 29(1-2):179-201. PubMed ID: 9631245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukocyte inhibitory factor (LIF) potentiates human macrophage aggregation and activation responses to calcium ionophore A23187 and directly induces leukotriene B4 and thromboxane A2 release.
    Conti P; Barbacane RC; Reale M; Panara MR; Placido FC; Mier JW; Castracane JM; Dempsey RA
    Biotechnol Ther; 1993; 4(3-4):239-52. PubMed ID: 8292972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of interleukin 1beta, tumor necrosis factor-alpha, and interstitial collagenase (MMP-1) is eicosanoid dependent in human osteoarthritis synovial membrane explants: interactions with antiinflammatory cytokines.
    He W; Pelletier JP; Martel-Pelletier J; Laufer S; Di Battista JA
    J Rheumatol; 2002 Mar; 29(3):546-53. PubMed ID: 11908571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Priming for the synthesis of 5-lipoxygenase products in human blood ex vivo by human granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-alpha.
    Palmantier R; Surette ME; Sanchez A; Braquet P; Borgeat P
    Lab Invest; 1994 May; 70(5):696-704. PubMed ID: 8196365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcription, translation and secretion of interleukin 1 and tumor necrosis factor: effects of tebufelone, a dual cyclooxygenase/5-lipoxygenase inhibitor.
    Sirko SP; Schindler R; Doyle MJ; Weisman SM; Dinarello CA
    Eur J Immunol; 1991 Feb; 21(2):243-50. PubMed ID: 1847874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paradoxical stimulation and inhibition by protein kinase C modulating agents of lipopolysaccharide evoked production of tumour necrosis factor in human monocytes.
    Coffey RG; Weakland LL; Alberts VA
    Immunology; 1992 May; 76(1):48-54. PubMed ID: 1628900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
    Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
    Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that cyclic AMP phosphodiesterase inhibitors suppress TNF alpha generation from human monocytes by interacting with a 'low-affinity' phosphodiesterase 4 conformer.
    Souness JE; Griffin M; Maslen C; Ebsworth K; Scott LC; Pollock K; Palfreyman MN; Karlsson JA
    Br J Pharmacol; 1996 Jun; 118(3):649-58. PubMed ID: 8762090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of the priming effect of lipopolysaccharides on the biosynthesis of leukotriene B4 in chemotactic peptide-stimulated human neutrophils.
    Surette ME; Dallaire N; Jean N; Picard S; Borgeat P
    FASEB J; 1998 Nov; 12(14):1521-31. PubMed ID: 9806761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.